Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient
By:
References
- Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012; 25: 264–96.
- Kasper LH. Toxoplasma infections. In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, et al., editors. Harrison’s principles of internal medicine. 17th Edition. New York: McGraw Hill Medical; 2008. p. 1305–11.
- Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 12; 363(9425): 1965–76.
- Schmidt-Hieber M, Zweigner J, Uharek L, Blau IW, Thiel E. Central nervous system infections in immunocompromised patients: update on diagnostics and therapy. Leuk Lymphoma 2009; 50: 24–36.
- Yan J, Huang B, Liu G, Wu B, Huang S, Zheng H, et al. Meta-analysis of prevention and treatment of toxoplasmic encephalitis in HIV-infected patients. Acta Trop 2013; 127: 236–44.
- Mele A, Paterson P, Prentice H, Leoni P, Kibbler C. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant 2002; 29: 691–8.
- Da Cunha S, Ferreira E, Ramos I, Martins R. Cerebral toxoplasmosis after renal transplantation. Case report and review. Acta Medica Port 1994; 7: 61–6.
- Abdel Razek AA, Watcharakorn A, Castillo M. Parasitic diseases of the central nervous system. Neuroimaging Clin N Am 2011; 21: 815–41.
- Offiah CE, Turnbull IW. The imaging appearances of intracranial CNS infections in adult HIV and AIDS patients. Clin Radiol 2006; 61: 393–401.
- Masamed R, Meleis A, Lee EW, Hathout GM. Cerebral toxoplasmosis: case review and description of a new imaging sign. Clin Radiol 2009; 64: 560–3.
- Ionita C, Wasay M, Balos L, Bakshi R. MR imaging in toxoplasmosis encephalitis after bone marrow transplantation: paucity of enhancement despite fulminant disease. Am J Neuroradiol 2004; 25: 270–3.
- Miller RF, Hall-Craggs MA, Costa DC, Brink NS, Scaravilli F, Lucas SB, et al. Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS. Sex Transm Infect 1998; 74: 258–64.
- Camacho DL a, Smith JK, Castillo M. Differentiation of toxoplasmosis and lymphoma in AIDS patients by using apparent diffusion coefficients. Am J Neuroradiol 2003; 24: 633–7.
- Sarrazin JL, Bonneville F, Martin-Blondel G. Brain infections. Diagn Interv Imaging 2012; 93: 473–90.
- Maza S, Buchert R, Brenner W, Munz DL, Thiel E, Korfel A, et al. Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma. Radiol Oncol 2013; 47: 103–110.
- Abedalthagafi M, Rushing EJ, Garvin D, Cheson B, Ozdemirli M. Asymptomatic diffuse “encephalitic” cerebral toxoplasmosis in a patient with chronic lymphocytic leukemia: case report and review of the literature. Int J Clin Exp Pathol 2009; 3: 106–9.
- Touahri T, Pulik M, Fezoui H, Genet P, Lionnet F, Louvel D. Toxoplasmic encephalitis in a non-HIV patient with follicular lymphoma. Int J Hematol 2002; 75: 111–2.
- Marcus R, Hagenbeek A. The therapeutic use of rituximab in non-Hodgkin’s lymphoma. Eur J Haematol Suppl 2007; 67: 5–14.
- Lanini S, Molloy AC, Prentice AG, Ippolito G, Kibbler CC. Infections in patients taking rituximab for hematologic malignancies: two-year cohort study. BMC Infect Dis 2013; 13: 317.
- Eisenberg R. Update on rituximab. Ann Rheum Dis 2005; 64(Suppl 4): iv55-7.
- Gürcan HM, Keskin DB, Stern JNH, Nitzberg MA, Shekhani H, Ahmed AR. A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol 2009; 9: 10–25.
- Kelesidis T, Daikos G, Boumpas D, Tsiodras S. Does rituximab increase the incidence of infectious complications? A narrative review. Int J Infect Dis 2011; 15: e2–16.
- Amezcua Vesely MC, Bermejo DA, Montes CL, Acosta-Rodríguez EV, Gruppi A. B-Cell response during protozoan parasite infections. J Parasitol Res 2012; 2012: 362131.
- Safa G, Darrieux L. Cerebral toxoplasmosis after rituximab therapy. JAMA Intern Med 2013; 173: 924–6.
- Derouin F, Pelloux H. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect 2008; 14: 1089–101.
- Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58(RR-4): 1–207.
- Soave R. Prophylaxis strategies for solid-organ transplantation. Clin Infect Dis 2001; 33(Suppl 1): S26-31.
Language: English
Page range: 87 - 93
Submitted on: May 27, 2014
Accepted on: Aug 21, 2014
Published on: Feb 16, 2016
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2016 Lina Savsek, Tanja Ros Opaskar, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.